Russian Experience of Bosutinib Use in Chronic Myeloid Leukemia Patients in Routine Clinical Practice

被引：0
|
作者：
Shuvaev, Vasily [1 ]
Vinogradova, Olga [2 ,3 ,4 ]
Martynkevich, Irina [1 ]
Natalya, Novitskaya [2 ]
Fominykh, Mikhail [5 ]
Tsareva, Svetlana [6 ]
Shikhbabaeva, Dzhariyat [2 ]
Pankrashkina, Maria [2 ,3 ]
Chernikov, Mikhail [2 ]
Sharkunov, Nikolay [2 ]
Zotova, Irina [5 ]
Udaleva, Vera [5 ]
Motyko, Ekaterina [5 ]
Voloshin, Sergei [1 ,7 ,8 ]
机构：
[1] Fed Med Biol Agcy, Russian Sci Res Inst Hematol & Transfusiol, Fed State Budget Inst, St Petersburg, Russia
[2] Botkin City Clin Hosp, Hematol Moscow City Ctr, Moscow, Russia
[3] Dmitry Rogachev Natl Res Ctr Pediat Hematol Oncol, Moscow, Russia
[4] Pirogov Russian Natl Res Med Univ, Moscow, Russia
[5] Russian Res Inst Hematol & Transfusiol, St Petersburg, Russia
[6] Botkin City Hosp, Hematol Moscow City Ctr, Moscow, Russia
[7] Mil Med Acad, St Petersburg, Russia
[8] North Western State Med Univ, St Petersburg, Russia
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-114164
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5446
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [42] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [43] 30Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice
    Cortes, Jorge E.
    Chen, Clara
    Mauro, Michael J.
    Sen, Ginny P.
    Gajavelli, Srikanth
    Davis, Catherine
    Goldberg, Stuart L.
    BLOOD, 2018, 132
  • [44] EFFICACY AND SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA - SYSTEMATIC REVIEW AND META-ANALYSIS
    Siderova, P.
    Kamusheva, M.
    Mitov, K.
    PHARMACIA, 2016, 63 (01) : 22 - 28
  • [45] CHRONIC MYELOID LEUKEMIA COMPLICATED WITH BILATERAL PLEURAL EFFUSIONS SECONDARY TO BOSUTINIB
    Salem, Amr
    Rihawi, Anas
    Salem, Ahmed A.
    Mousa, Amer Alshekh
    Bates, Noelle
    Soliman, Mohanad
    CHEST, 2022, 162 (04) : 1433A - 1434A
  • [46] Imatinib plasma levels in patients with chronic myeloid leukaemia under routine clinical practice conditions
    Garcia, Betel Del Rosario
    Garcia, Iris Gonzalez
    Vina Romero, Maria Micaela
    Garcia, Jonathan Gonzalez
    Diaz, Ruth Ramos
    Padron, Ivette Mourani
    Lakhwani, Sunil Lakhwani
    Nazco Casariego, Gloria Julia
    Nicolas, Fernando Gutierrez
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 40 - 44
  • [47] Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia
    Ercaliskan, Abdulkadir
    Eskazan, Ahmet Emre
    FUTURE ONCOLOGY, 2020, 16 (03) : 4425 - 4428
  • [48] Population modeling of bosutinib exposure-response in patients with newly diagnosed chronic phase chronic myeloid leukemia
    Garrett, May
    Knight, Beverly
    Cortes, Jorge E.
    Deininger, Michael W.
    CANCER MEDICINE, 2023, 12 (17): : 17981 - 17992
  • [49] Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
    Hochhaus, Andreas
    Gambacorti-Passerini, Carlo
    Abboud, Camille
    Gjertsen, Bjorn Tore
    Bruemmendorf, Tim H.
    Smith, B. Douglas
    Ernst, Thomas
    Giraldo-Castellano, Pilar
    Olsson-Stromberg, Ulla
    Saussele, Susanne
    Bardy-Bouxin, Nathalie
    Viqueira, Andrea
    Leip, Eric
    Russell-Smith, T. Alexander
    Leone, Jocelyn
    Rosti, Gianantonio
    Watts, Justin
    Giles, Francis J.
    LEUKEMIA, 2020, 34 (08) : 2125 - 2137
  • [50] Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
    Andreas Hochhaus
    Carlo Gambacorti-Passerini
    Camille Abboud
    Bjørn Tore Gjertsen
    Tim H. Brümmendorf
    B. Douglas Smith
    Thomas Ernst
    Pilar Giraldo-Castellano
    Ulla Olsson-Strömberg
    Susanne Saussele
    Nathalie Bardy-Bouxin
    Andrea Viqueira
    Eric Leip
    T. Alexander Russell-Smith
    Jocelyn Leone
    Gianantonio Rosti
    Justin Watts
    Francis J. Giles
    Leukemia, 2020, 34 : 2125 - 2137
12345